1. Home
  2. TECX vs FRA Comparison

TECX vs FRA Comparison

Compare TECX & FRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$20.50

Market Cap

413.3M

Sector

N/A

ML Signal

N/A

Logo Blackrock Floating Rate Income Strategies Fund Inc

FRA

Blackrock Floating Rate Income Strategies Fund Inc

N/A

Current Price

$9.82

Market Cap

367.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
FRA
Founded
2019
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
413.3M
367.5M
IPO Year
2018
2003

Fundamental Metrics

Financial Performance
Metric
TECX
FRA
Price
$20.50
$9.82
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
★ $71.00
N/A
AVG Volume (30 Days)
158.1K
★ 171.7K
Earning Date
11-05-2026
01-01-0001
Dividend Yield
N/A
★ 11.06%
EPS Growth
★ 40.70
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.77
$9.65
52 Week High
$39.53
$12.23

Technical Indicators

Market Signals
Indicator
TECX
FRA
Relative Strength Index (RSI) 44.54 32.94
Support Level $20.52 $9.65
Resistance Level $22.95 $11.20
Average True Range (ATR) 1.29 0.12
MACD 0.19 -0.02
Stochastic Oscillator 44.43 11.90

Price Performance

Historical Comparison
TECX
FRA

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About FRA Blackrock Floating Rate Income Strategies Fund Inc

Blackrock Floating Rate Inc Stra Fd Inc is a closed-end management investment company. Its investment objective is to provide shareholders with high current income and such preservation of capital as is consistent with investment in a diversified, leveraged portfolio consisting of floating rate debt securities and instruments. The Fund seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its managed assets in floating rate debt securities, including floating or variable rate debt securities that pay interest at rates that adjust whenever a specified interest rate changes and/or which reset on predetermined dates (such as the last day of a month or calendar quarter).

Share on Social Networks: